The Latin America hypodermic syringes and needles market size is projected to reach USD 305.59 million by 2030. The market is anticipated to expand at a CAGR of 5.7% from 2023 to 2030. An increasing number of mass vaccination programs and rising awareness regarding various chronic conditions are factors boosting the demand for the hypodermic syringes and needles market.
Moreover, increasing efforts to reduce the transmission of diseases and create awareness regarding safe drug delivery practices by government organizations such as WHO and the UN are also expected to lead to the industry’s growth. These organizations have undertaken several initiatives for safe drug delivery. Some of the programs conducted by these organizations are needle & syringe programs; prevention & treatment of sexually transmitted infections; targeted information; and education & communication for Injecting Drug Users (IDUs) and their sexual partners.
The COVID-19 pandemic had a positive impact on the market due to the increasing demand for vaccines to reduce the mortality rate and to control the severity of the virus in patients with the risk of being infected with it. The demand for syringes and needles witnessed a tremendous upsurge and many companies had to increase their production capacities to a great extent. With new anticipated COVID-19 waves and an increasing number of pharmaceutical companies continuously working towards introducing booster doses, the market is further anticipated to experience significant growth over the forecast as well.
This product will be delivered within 1-3 business days.
Moreover, increasing efforts to reduce the transmission of diseases and create awareness regarding safe drug delivery practices by government organizations such as WHO and the UN are also expected to lead to the industry’s growth. These organizations have undertaken several initiatives for safe drug delivery. Some of the programs conducted by these organizations are needle & syringe programs; prevention & treatment of sexually transmitted infections; targeted information; and education & communication for Injecting Drug Users (IDUs) and their sexual partners.
The COVID-19 pandemic had a positive impact on the market due to the increasing demand for vaccines to reduce the mortality rate and to control the severity of the virus in patients with the risk of being infected with it. The demand for syringes and needles witnessed a tremendous upsurge and many companies had to increase their production capacities to a great extent. With new anticipated COVID-19 waves and an increasing number of pharmaceutical companies continuously working towards introducing booster doses, the market is further anticipated to experience significant growth over the forecast as well.
Latin America Hypodermic Syringes and Needles Market Report Highlights
- The syringes segment dominated the market in 2022 due to the increasing adoption rate and higher price as compared to needles
- The combination segment held the second-highest share in 2022 owing to the increasing adoption of these products to administer insulin
- Brazil held the highest market share in 2022 owing to the huge COVID-19 patient pool in the country, and better availability of healthcare facilities as compared to the other countries
- Due to the rising number of the outbreak of diseases, Venezuela is anticipated to experience maximum growth in the market over the forecast period
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type Outlook
2.2.2. Regional Outlook
2.3. Competitive Insights
Chapter 3. Latin America Hypodermic Syringes and Needles Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Rise in the prevalence of diabetes, asthma, and other serious allergies
3.4.1.2. Increase in the number of initiatives by government organizations
3.4.1.3. Impact of Covid-19 pandemic.
3.4.2. Market restraint analysis
3.4.2.1. Frequent product recalls
3.4.2.2. Presence of alternatives
3.5. Latin America Hypodermic Syringes and Needles Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Latin America Hypodermic Syringes and Needles: Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Needles
4.1.2. Syringes
4.1.3. Combination
4.2. Type Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Latin America Hypodermic Syringes and Needles Market by Type Outlook
4.5. Market Product & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Needles
4.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.1.2. 16-18G
4.5.1.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.1.3. 19-21G
4.5.1.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.1.4. 22-25G
4.5.1.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.1.5. 26-29G
4.5.1.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.1.6. 30-32G
4.5.1.6.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2. Syringes
4.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.2. 1-5ml
4.5.2.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.3. 5-10ml
4.5.2.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.4. 11-15ml
4.5.2.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.5. 16-20ml
4.5.2.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.6. 21-25ml
4.5.2.6.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.7. 26-30ml
4.5.2.7.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.8. 31-35ml
4.5.2.8.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.9. 36-40ml
4.5.2.9.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.10. 41-45ml
4.5.2.10.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.11. 46-50ml
4.5.2.11.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.3. Combination
4.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
Chapter 5. Latin America Hypodermic Syringes and Needles Market: Regional Estimates & Trend Analysis
5.1. Regional market share analysis, 2022 & 2030
5.2. Regional Market Dashboard
5.3. Global Regional Market Snapshot
5.4. Regional Market Share and Leading Players, 2022
5.4.1. Latin America
5.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
5.5.1. Latin America
5.6. Market Product, & Forecasts and Trend Analysis, 2018 to 2030:
5.7. Latin America
5.7.1. Brazil
5.7.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.2. Mexico
5.7.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.3. Argentina
5.7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.4. Colombia
5.7.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.5. Chile
5.7.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.6. Uruguay
5.7.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.7. Venezuela
5.7.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.8. Bolivia
5.7.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.9. Peru
5.7.9.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.10. Ecuador
5.7.10.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.2.1. Innovators
6.2.2. Market Leaders
6.2.3. Emerging Players
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company market share analysis, 2022
6.3.4. Cardinal Health Inc.
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Terumo Corporation
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. BD
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. Nipro Corporation
6.3.7.1. Overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives
6.3.8. B.Braun Melsungen
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. Smiths Medical, Inc.
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
6.3.10. Lifelong Meditech Private Limited
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Product benchmarking
6.3.10.4. Strategic initiatives
6.3.11. Exelint International, Co.
6.3.11.1. Company overview
6.3.11.2. Financial performance
6.3.11.3. Product benchmarking
6.3.11.4. Strategic initiatives
6.3.12. Vitrex Medical A/S
6.3.12.1. Company overview
6.3.12.2. Financial performance
6.3.12.3. Product benchmarking
6.3.12.4. Strategic initiatives
6.3.13. Retractable Technologies, Inc.
6.3.13.1. Company overview
6.3.13.2. Financial performance
6.3.13.3. Product benchmarking
6.3.13.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 Latin America hypodermic syringes and needles market, by region, 2018 - 2030 (USD Million)
Table 3 Latin America hypodermic syringes and needles market, by type, 2018 - 2030 (USD Million)
Table 4 Brazil hypodermic syringes and needles market, by type, 2018 - 2030 (USD Million)
Table 5 Mexico hypodermic syringes and needles market, by type, 2018 - 2030 (USD Million)
Table 6 Argentina hypodermic syringes and needles market, by type, 2018 - 2030 (USD Million)
Table 7 Colombia hypodermic syringes and needles market, by type, 2018 - 2030 (USD Million)
Table 8 Chile hypodermic syringes and needles market, by type, 2018 - 2030 (USD Million)
Table 9 Uruguay hypodermic syringes and needles market, by type, 2018 - 2030 (USD Million)
Table 10 Venezuela hypodermic syringes and needles market, by type, 2018 - 2030 (USD Million)
Table 11 Bolivia hypodermic syringes and needles market, by type, 2018 - 2030 (USD Million)
Table 12 Peru hypodermic syringes and needles market, by type, 2018 - 2030 (USD Million)
Table 13 Ecuador hypodermic syringes and needles market, by type, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in Latin America
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Hypodermic syringes and needles: market outlook
Fig. 10 Hypodermic syringes and needles market competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 Hypodermic syringes and needles market driver impact
Fig. 16 Hypodermic syringes and needles market restraint impact
Fig. 17 Hypodermic syringes and needles market strategic initiatives analysis
Fig. 18 Hypodermic syringes and needles market: type movement analysis
Fig. 19 Hypodermic syringes and needles market: type outlook and key takeaways
Fig. 20 Needles estimates and forecast, 2018 - 2030
Fig. 21 16-18G estimates and forecast, 2018 - 2030
Fig. 22 19-21G estimates and forecast, 2018 - 2030
Fig. 23 22-25G estimates and forecast, 2018 - 2030
Fig. 24 26-29G estimates and forecast, 2018 - 2030
Fig. 25 30-32G estimates and forecast, 2018 - 2030
Fig. 26 Syringes estimates and forecast, 2018 - 2030
Fig. 27 1-5 ml estimates and forecast, 2018 - 2030
Fig. 28 6-10 ml estimates and forecast, 2018 - 2030
Fig. 29 11-15 ml estimates and forecast, 2018 - 2030
Fig. 30 16-20 ml estimates and forecast, 2018 - 2030
Fig. 31 21-25 ml estimates and forecast, 2018 - 2030
Fig. 32 26-30 ml estimates and forecast, 2018 - 2030
Fig. 33 31-35 ml estimates and forecast, 2018 - 2030
Fig. 34 36-40 ml estimates and forecast, 2018 - 2030
Fig. 35 41-45 ml estimates and forecast, 2018 - 2030
Fig. 36 46-50 ml estimates and forecast, 2018 - 2030
Fig. 37 Combination estimates and forecast, 2018 - 2030
Fig. 38 Global Hypodermic syringes and needles market: regional outlook and key takeaways
Fig. 39 Latin America market share and leading players
Fig. 40 Latin America SWOT
Fig. 41 Latin America
Fig. 42 Latin America market estimates and forecast, 2018 - 2030
Fig. 43 Brazil
Fig. 44 Brazil market estimates and forecast, 2018 - 2030
Fig. 45 Mexico
Fig. 46 Mexico market estimates and forecast, 2018 - 2030
Fig. 47 Argentina
Fig. 48 Argentina market estimates and forecast, 2018 - 2030
Fig. 49 Colombia
Fig. 50 Colombia market estimates and forecast, 2018 - 2030
Fig. 51 Chile
Fig. 52 Chile market estimates and forecast, 2018 - 2030
Fig. 53 Uruguay
Fig. 54 Uruguay market estimates and forecast, 2018 - 2030
Fig. 55 Venezuela
Fig. 56 Venezuela market estimates and forecast, 2018 - 2030
Fig. 57 Bolivia
Fig. 58 Bolivia market estimates and forecast, 2018 - 2030
Fig. 59 Peru
Fig. 60 Peru market estimates and forecast, 2018 - 2030
Fig. 61 Ecuador
Fig. 62 Ecuador market estimates and forecast, 2018 - 2030
Fig. 63 Participant categorization- Hypodermic syringes and needles market
Fig. 64 Market share of key market players- Hypodermic syringes and needles market
Companies Mentioned
- Cardinal Health Inc.
- Terumo Corporation
- BD
- Nipro Corporation
- B.Braun Melsungen
- Smiths Medical, Inc.
- Lifelong Meditech Private Limited
- Exelint International, Co.
- Vitrex Medical A/S
- Retractable Technologies, Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 95 |
| Published | January 2023 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 205.75 Million |
| Forecasted Market Value ( USD | $ 305.59 Million |
| Compound Annual Growth Rate | 5.7% |
| Regions Covered | Latin America |
| No. of Companies Mentioned | 10 |
